9225 Hodgkin Lymphoma Treatment With ABVD in the US and the EU: Neutropenia Occurrence and Impaired Chemotherapy Delivery

European Journal of Cancer, Supplement - United Kingdom
doi 10.1016/s1359-6349(09)71916-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Advances in Hematology
Hematology
2011English

Maternal ABVD Chemotherapy for Hodgkin Lymphoma in a Dichorionic Diamniotic Pregnancy: A Case Report

BMC Pregnancy and Childbirth
GynecologyObstetrics
2020English

Occurrence of Sarcoidosis After Chemotherapy for Non-Hodgkin Lymphoma

Korean Journal of Internal Medicine
Internal Medicine
2016English

Excellent Outcome in Hodgkin Lymphoma With ABVD and CMT: A Single-Centre Retrospective Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cost-Effectiveness and Cost-Utility Analysis of Multiple Treatment Strategies Using Abvd and/or Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Risk Factors for Chemotherapy-Induced Neutropenia Occurrence in Breast Cancer Patients: Data From the INC-EU Prospective Observational European Neutropenia Study

Supportive Care in Cancer
Oncology
2010English

Rituximab Plus ABVD in Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

British Journal of Haematology
Hematology
2016English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie
Oncology
2016English

Limited-Stage Hodgkin Lymphoma: Optimal Chemotherapy and the Role of Radiotherapy

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy